Dihydroergotamine protects against ischemic stroke by modulating microglial/macrophage polarization and inhibiting inflammation in mice

References

• Kim JS. tPA helpers in the treatment of acute ischemic stroke: are they ready for clinical use? J Stroke. 2019;21(2):160–174. doi: 10.5853/jos.2019.00584
   PubMed Web of Science ®Google Scholar
• Hollist M, Morgan L, Cabatbat R, et al. Acute stroke management: overview and recent updates. Aging Dis. 2021;12(4):1000–1009. doi: 10.14336/AD.2021.0311
   PubMed Web of Science ®Google Scholar
• Eren F, Yilmaz S. Neuroprotective approach in acute ischemic stroke: a systematic review of clinical and experimental studies. Brain Circ. 2022;8(4):172–179. doi: 10.4103/bc.bc_52_22
   PubMedGoogle Scholar
• Tfelt-Hansen PC, Koehler PJ. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia. 2008;28(8):877–86. doi: 10.1111/j.1468-2982.2008.01578.x
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Kori SH, Borland SW, et al. Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia. Headache. 2012;52(1):37–47. doi: 10.1111/j.1526-4610.2011.02041.x
   PubMed Web of Science ®Google Scholar
• Gornemann T, Jahnichen S, Schurad B, et al. Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes. Naunyn-Schmiedeberg’s Arch Pharmacol. 2008;376(5):321–330. doi: 10.1007/s00210-007-0221-3
   Google Scholar
• Tfelt-Hansen P. Ergotamine, dihydroergotamine: current uses and problems. Curr Med Res Opin. 2001;17(Suppl 1):s30–4. doi: 10.1185/0300799039117009
   PubMedGoogle Scholar
• Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache. 2003;43(2):144–66. doi: 10.1046/j.1526-4610.2003.03034.x
   PubMed Web of Science ®Google Scholar
• Burki HR, Asper H, Ruch W, et al. Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25–397, and 29–712: effects on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacol (Berl). 1978;57(3):227–237. doi: 10.1007/BF00426743
   PubMed Web of Science ®Google Scholar
• Le Poncin-Lafitte M, Grosdemouge C, Duterte D, et al. Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline. Gerontology. 1984;30(2):109–119. doi: 10.1159/000212616
   PubMedGoogle Scholar
• Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and stroke risk: a new target for prevention. Stroke. 2021;52(8):2697–2706. doi: 10.1161/STROKEAHA.121.034388
   PubMed Web of Science ®Google Scholar
• Lyu J, Xie D, Bhatia TN, et al. Microglial/macrophage polarization and function in brain injury and repair after stroke. CNS Neurosci Ther. 2021;27(5):515–527. doi: 10.1111/cns.13620
   PubMed Web of Science ®Google Scholar
• Wang Y, Leak RK, Cao G. Microglia-mediated neuroinflammation and neuroplasticity after stroke. Front Cell Neurosci. 2022;16:980722. doi: 10.3389/fncel.2022.980722
   PubMed Web of Science ®Google Scholar
• Yu F, Wang Y, Stetler AR, et al. Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci Ther. 2022;28(9):1279–1293. doi: 10.1111/cns.13899
   PubMed Web of Science ®Google Scholar
• Zhao SC, Ma LS, Chu ZH, et al. Regulation of microglial activation in stroke. Acta Pharmacol Sin. 2017;38(4):445–458. doi: 10.1038/aps.2016.162
   PubMed Web of Science ®Google Scholar
• Li F, Zhao H, Han Z, et al. Xuesaitong May protect against ischemic stroke by modulating microglial phenotypes and inhibiting neuronal cell apoptosis via the STAT3 signaling pathway. CNS Neurol Disord Drug Targets. 2019;18(2):115–123. doi: 10.2174/1871527317666181114140340
   PubMed Web of Science ®Google Scholar
• Rivera-Mancilla E, Aviles-Rosas VH, Manrique-Maldonado G, et al. The role of alpha(1)- and alpha(2)-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats. J Headache Pain. 2017;18(1):104. doi: 10.1186/s10194-017-0812-4
   PubMedGoogle Scholar
• Rolinski Z, Scheel-Kruger J. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats. Acta Pharmacol Toxicol (Copenh). 1973;33(5):385–399. doi: 10.1111/j.1600-0773.1973.tb01540.x
   PubMedGoogle Scholar
• Chen S, Dong Z, Cheng M, et al. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation. 2017;14(1):187. doi: 10.1186/s12974-017-0963-x
   PubMedGoogle Scholar
• Shen H, Pei H, Zhai L, et al. Salvianolic acid C improves cerebral ischemia reperfusion injury through suppressing microglial cell M1 polarization and promoting cerebral angiogenesis. Int Immunopharmacol. 2022;110:109021. doi: 10.1016/j.intimp.2022.109021
   PubMed Web of Science ®Google Scholar
• Zhao N, Xu X, Jiang Y, et al. Lipocalin-2 may produce damaging effect after cerebral ischemia by inducing astrocytes classical activation. J Neuroinflammation. 2019;16(1):168. doi: 10.1186/s12974-019-1556-7
   PubMed Web of Science ®Google Scholar
• Jiang CT, Wu WF, Deng YH, et al. Modulators of microglia activation and polarization in ischemic stroke (review). Mol Med Rep. 2020;21(5):2006–2018. doi: 10.3892/mmr.2020.11003
   PubMed Web of Science ®Google Scholar
• Wang J, Xing H, Wan L, et al. Treatment targets for M2 microglia polarization in ischemic stroke. Biomed Pharmacother = Biomed Pharmacotherapie. 2018;105:518–525. doi: 10.1016/j.biopha.2018.05.143
   PubMed Web of Science ®Google Scholar
• Hersi AI, Kitaichi K, Srivastava LK, et al. Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Res Mol Brain Res. 2000;76(2):336–40. doi: 10.1016/S0169-328X(00)00015-2
   PubMedGoogle Scholar
• Sozmen EY, Kanit L, Kutay FZ, et al. Possible supportive effects of co-dergocrine mesylate on antioxidant enzyme systems in aged rat brain. Eur Neuropsychopharmacol. 1998;8(1):13–6. doi: 10.1016/S0924-977X(97)00039-4
   PubMed Web of Science ®Google Scholar
• McArthur RA, Carfagna N, Banfi L, et al. Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels. Brain Res Bull. 1997;43(3):305–11. doi: 10.1016/S0361-9230(97)00010-5
   PubMed Web of Science ®Google Scholar
• Hoskin KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-fos and electrophysiological study. Brain. 1996;119(Pt 1):249–256. doi: 10.1093/brain/119.1.249
   PubMedGoogle Scholar
• Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia. 1988;8(2):83–91. doi: 10.1046/j.1468-2982.1988.0802083.x
   PubMed Web of Science ®Google Scholar
• Bednarczuk NF, Lim M, Siddiqui A, et al. Ischemic Stroke Following Ergotamine Overdose. Pediatr Neurol. 2019;101:81–82. doi: 10.1016/j.pediatrneurol.2019.07.016
   PubMed Web of Science ®Google Scholar
• DeLong JH, Ohashi SN, O’Connor KC, et al. Inflammatory responses after ischemic stroke. Semin Immunopathol. 2022;44(5):625–648. doi: 10.1007/s00281-022-00943-7
   PubMed Web of Science ®Google Scholar
• Zhao B, Zou CJ, Zhou P. Delayed administration IL-1beta neutralizing antibody improves cognitive function after transient global ischemia in rats. Behav Brain Res. 2016;303:53–60. doi: 10.1016/j.bbr.2016.01.028
   PubMed Web of Science ®Google Scholar
• Samy ZA, Al-Abdullah L, Turcani M, et al. Rat astrocytes during anoxia: secretome profile of cytokines and chemokines. Brain Behav. 2018;8(7):e01013. doi: 10.1002/brb3.1013
   PubMed Web of Science ®Google Scholar
• Mauro AG, Mezzaroma E, Torrado J, et al. Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha. J Cardiovasc Pharmacol. 2017;69(3):156–160. doi: 10.1097/FJC.0000000000000452
   PubMed Web of Science ®Google Scholar
• Palomino-Antolin A, Narros-Fernandez P, Farre-Alins V, et al. Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia. Br J Pharmacol. 2022;179(7):1395–1410. doi: 10.1111/bph.15732
   PubMed Web of Science ®Google Scholar
• Chen AQ, Fang Z, Chen XL, et al. Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis. 2019;10(7):487. doi: 10.1038/s41419-019-1716-9
   PubMedGoogle Scholar
• Cui G, Wang H, Li R, et al. Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke. J Neuroinflammation. 2012;9(1):235. doi: 10.1186/1742-2094-9-235
   PubMedGoogle Scholar
• Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, et al. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol. 2019;70(2):209–217.
   Web of Science ®Google Scholar
• Tuttolomondo A, Pecoraro R, Pinto A. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Drug Design Develop Therapy. 2014;8:2221–38. doi: 10.2147/DDDT.S67655
   PubMed Web of Science ®Google Scholar
• Xiong XY, Liu L, Yang QW. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog Neurobiol. 2016;142:23–44. doi: 10.1016/j.pneurobio.2016.05.001
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen S, Luo Y, et al. Crosstalk between inflammation and the BBB in stroke. Curr Neuropharmacol. 2020;18(12):1227–1236. doi: 10.2174/1570159X18666200620230321
   PubMed Web of Science ®Google Scholar
• Yu H, Wang X, Kang F, et al. Propofol attenuates inflammatory damage on neurons following cerebral infarction by inhibiting excessive activation of microglia. Int J Mol Med. 2019;43(1):452–460. doi: 10.3892/ijmm.2018.3974
   PubMed Web of Science ®Google Scholar
• Chen T, Li Z, Li S, et al. Cycloastragenol suppresses M1 and promotes M2 polarization in LPS-stimulated BV-2 cells and ischemic stroke mice. Int Immunopharmacol. 2022;113(Pt A):109290. doi: 10.1016/j.intimp.2022.109290
   PubMedGoogle Scholar
• Paolicelli RC, Sierra A, Stevens B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110(21):3458–3483. doi: 10.1016/j.neuron.2022.10.020
   PubMed Web of Science ®Google Scholar